1. Home
  2. BNGO vs HBIO Comparison

BNGO vs HBIO Comparison

Compare BNGO & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • HBIO
  • Stock Information
  • Founded
  • BNGO 2003
  • HBIO 1901
  • Country
  • BNGO United States
  • HBIO United States
  • Employees
  • BNGO N/A
  • HBIO N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • BNGO Industrials
  • HBIO Industrials
  • Exchange
  • BNGO Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • BNGO 24.3M
  • HBIO 24.6M
  • IPO Year
  • BNGO 2018
  • HBIO 2000
  • Fundamental
  • Price
  • BNGO $1.95
  • HBIO $0.42
  • Analyst Decision
  • BNGO Buy
  • HBIO Buy
  • Analyst Count
  • BNGO 4
  • HBIO 3
  • Target Price
  • BNGO $7.67
  • HBIO $2.50
  • AVG Volume (30 Days)
  • BNGO 1.6M
  • HBIO 1.1M
  • Earning Date
  • BNGO 11-12-2025
  • HBIO 11-06-2025
  • Dividend Yield
  • BNGO N/A
  • HBIO N/A
  • EPS Growth
  • BNGO N/A
  • HBIO N/A
  • EPS
  • BNGO N/A
  • HBIO N/A
  • Revenue
  • BNGO $27,426,000.00
  • HBIO $88,750,000.00
  • Revenue This Year
  • BNGO N/A
  • HBIO N/A
  • Revenue Next Year
  • BNGO $24.54
  • HBIO $7.02
  • P/E Ratio
  • BNGO N/A
  • HBIO N/A
  • Revenue Growth
  • BNGO N/A
  • HBIO N/A
  • 52 Week Low
  • BNGO $1.50
  • HBIO $0.28
  • 52 Week High
  • BNGO $25.65
  • HBIO $2.82
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 39.67
  • HBIO 39.10
  • Support Level
  • BNGO $1.63
  • HBIO $0.43
  • Resistance Level
  • BNGO $2.15
  • HBIO $0.45
  • Average True Range (ATR)
  • BNGO 0.12
  • HBIO 0.02
  • MACD
  • BNGO 0.08
  • HBIO -0.00
  • Stochastic Oscillator
  • BNGO 60.64
  • HBIO 11.97

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: